Anti-CD41 [7E3 (Abciximab)]
Ab00282-13.0
ApplicationsFlow Cytometry, Neutralisation/Blocking
Product group Antibodies
ReactivityHuman
TargetITGA2B
Overview
- SupplierAbsolute Antibody
- Product NameAnti-CD41 [7E3 (Abciximab)]
- Delivery Days Customer7
- Antibody SpecificityRecognises human CD41.
- ApplicationsFlow Cytometry, Neutralisation/Blocking
- Applications SupplierBlock; Fc
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID7E3 (Abciximab)
- Gene ID3674
- Target nameITGA2B
- Target descriptionintegrin subunit alpha 2b
- Target synonymsalphaIIb protein; BDPLT16; BDPLT2; CD41; CD41B; GP2B; GPalpha IIb; GPIIb; GT; GT1; GTA; HPA3; integrin alpha-IIb; integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41); platelet fibrinogen receptor, alpha subunit; platelet glycoprotein IIb of IIb/IIIa complex; platelet membrane glycoprotein IIb; platelet-specific antigen BAK; PPP1R93; protein phosphatase 1, regulatory subunit 93
- HostHuman
- IsotypeIgG4
- Protein IDP08514
- Protein NameIntegrin alpha-IIb
- Scientific DescriptionThis is a reformatted human IgG4 antibody based on the therapeutic Fab fragment. NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.
- ReactivityHuman
- Reactivity SupplierHuman
- Reactivity Supplier NoteCD41 is the integrin alpha chain 2b forming a fibrinogen receptor in heterodimeric complex with beta 3.
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203